Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice

Andrew B Barbour1, Rituraj Upadhyay2, August C Anderson1

  • 1Department of Radiation Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington.

PubMed
Summary

Stereotactic body radiation therapy (SBRT) offers high local control for primary renal cell carcinoma (RCC). This guide provides practical considerations for SBRT in RCC, addressing challenging cases and patient-specific factors.

Related Concept Videos